Ocular Side Effects of Aromatase Inhibitor Endocrine Therapy in Breast Cancer - A Review

被引：9

作者：

Serban, Dragos ^{[1
,2
]}

Costea, Daniel Ovidiu ^{[3
,4
]}

Zgura, Anca ^{[5
,6
]}

Tudosie, Mihail Silviu ^{[7
,8
]}

Dascalu, Ana Maria ^{[9
,10
]}

Gangura, Gabriel Andrei ^{[1
,11
]}

Smarandache, Catalin Gabriel ^{[1
,2
]}

Sabau, Alexandru Dan ^{[12
,13
]}

Tudor, Corneliu ^{[2
]}

Faur, Mihai ^{[12
,13
]}

Costea, Andreea Cristina ^{[14
]}

Stana, Daniela ^{[10
]}

Balasescu, Simona Andreea ^{[2
]}

Tribus, Laura Carina ^{[15
,16
]}

Tanasescu, Ciprian ^{[12
,13
]}

机构：

[1] Carol DavilaUniv Med & Pharm, Dept Gen Surg, Fac Med, Bucharest, Romania

[2] Emergency Univ Hosp, Dept Surg Emergency 4, Bucharest, Romania

[3] Ovidius Univ, Fac Med, Dept Clin Surg Disciplines 1, Constanta, Romania

[4] Emergency Cty Hosp, Surg Dept 1, Constanta, Romania

[5] Carol DavilaUniv Med & Pharm, Fac Med, Dept Oncol Radiol & Hematol, Bucharest, Romania

[6] Inst Oncol Prof Dr Alexandru Trestioreanu, Dept Oncol Radiotherapy, Bucharest, Romania

[7] Carol Davila Univ Med & Pharm, Fac Med, Dept Orthopedia & Intens Care, Bucharest, Romania

[8] Clin Emergency Hosp, ICU Toxicol 2, Bucharest, Romania

[9] Carol Davila Univ Med & Pharm, Fac Med, Dept ENT Ophthalmol, Bucharest, Romania

[10] Emergency Univ Hosp, Ophthalmol Dept, Bucharest, Romania

[11] Emergency Univ Hosp, Dept Surg 2, Bucharest, Romania

[12] Lucian Blaga Univ, Fac Med, Surg Clin Dept, Sibiu, Romania

[13] Sibiu Cty Emergency Clin Hosp, Dept Surg, Sibiu, Romania

[14] Diaverum Clin, Nephrol & Dialysis Dept, Constanta, Romania

[15] Carol Davila Univ Med & Pharm, Dept Internal Med Gastroenterol, Fac Med, Bucharest, Romania

[16] Emergency Univ Hosp Bucharest, Gastroenterol Dept, Bucharest, Romania

来源：

IN VIVO | 2022年 / 36卷 / 01期

关键词：

Breast cancer; endocrine therapy; aromatase inhibitors; ocular side-effects; dry eye; anastrozole; review; DRY-EYE SYNDROME; POSTMENOPAUSAL WOMEN; ADJUVANT TREATMENT; TAMOXIFEN THERAPY; RANDOMIZED-TRIAL; SURFACE DISEASE; ANASTROZOLE; ESTROGEN; LETROZOLE; EXEMESTANE;

D O I：

10.21873/invivo.12674

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

in patients with breast cancer. Materials and Methods: A comprehensive search was performed on PubMed, Web of Science and Google scholar. Results: After duplication removal, 14 clinical studies and 5 case reports, published between 2008 and 2021, were identified. Most frequently, AI treatment resulted in minor to moderate dry eye symptoms. "De novo" onset of Sjogren syndrome during AI therapy was also reported. Retinal and optic nerve side effects varied from mild, subclinical anatomic and functional impairment to severe decreased vision, secondary to hemi-central retinal artery occlusion, bilateral optic neuritis or uveitis with bilateral macular edema. Conclusion: Visual disturbances encountered during AI treatment may be underestimated. Ophthalmic screening is important for early detection and appropriate treatment.

引用

页码：40 / 48

页数：9

共 50 条

[21] Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data
Grana, G.
JOURNAL OF SURGICAL ONCOLOGY, 2006, 93 (07) : 585 - 592
[22] NOCEBO EFFECTS IN BREAST CANCER TREATMENT: EXPECTATIONS PREDICT SIDE EFFECTS OF ENDOCRINE THERAPY
Nestoriuc, Y. N.
Von Blanckenburg, P.
Schuricht, F.
Albert, U.
Rief, W.
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2014, 21 : S133 - S134
[23] Onset of side effects and adherence to endocrine therapy in the Breast Cancer Endocrine Therapy Adherence (BETA) pilot study
Epstein, Lianne N.
Jhaveri, Ami P.
Han, Gang
Abu-Khalaf, Maysa M.
Hofstatter, Erin Wysong
Sanft, Tara Beth
DiGiovanna, Michael
Silber, Andrea
Adelson, Kerin B.
Chung, Gina G.
Gross, Cary Philip
Pusztai, Lajos
Mougalian, Sarah Schellhorn
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[24] Side-effects in women treated with adjuvant endocrine therapy for breast cancer
Rademaker, L. M.
Gal, R.
May, A. M.
Batenburg, M. C. T.
van der Leij, F.
Bijlsma, R. M.
Verkooijen, H. M.
Doeksen, A.
Ernst, M. F.
Evers, D. J.
van der Pol, C. C.
Monninkhof, E. M.
BREAST, 2025, 80
[25] CLINICAL AND ENDOCRINE EFFECTS OF THE ORAL AROMATASE INHIBITOR VOROZOLE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
JOHNSTON, SRD
SMITH, IE
DOODY, D
JACOBS, S
ROBERTSHAW, H
DOWSETT, M
CANCER RESEARCH, 1994, 54 (22) : 5875 - 5881
[26] First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen?
Z-W Wong
M J Ellis
British Journal of Cancer, 2004, 90 : 20 - 25
[27] First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen?
Wong, ZW
Ellis, MJ
BRITISH JOURNAL OF CANCER, 2004, 90 (01) : 20 - 25
[28] Endocrine Therapy for Advanced Breast Cancer: Beyond Tamoxifen and Aromatase Inhibitors
Guerrero-Zotano, Angel
Muggia, Franco
CURRENT CANCER THERAPY REVIEWS, 2010, 6 (01) : 51 - 61
[29] Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors
Ranger, GS
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2005, 30 (04) : 313 - 317
[30] Aromatase inhibitors in relation to other forms of endocrine therapy for breast cancer
Osborne, CK
ENDOCRINE-RELATED CANCER, 1999, 6 (02) : 271 - 276

← 1 2 3 4 5 →